There are a number of treatment strategies for neurotrophic keratopathy. Physicians discuss the different disease stages, management, and the FDA-approved medication available.
EyeWorld spoke with several experts for a comprehensive overview of three novel glaucoma medications.
All surgical specialties, particularly ophthalmology, are facing steep across-the-board cuts to reimbursement—through a reduction in the conversion factor—if the Centers for Medicare and Medicaid Services (CMS) 2021 policies for evaluation and management (E/M) go into effect without modification.
Monovision is a proven and trustworthy option to attain spectacle independence in patients undergoing cataract surgery. According to Ehud Assia, MD, the best results are attained by waiting for the outcomes of the first-eye surgery before moving on the create monovision.
Many ophthalmologists have fielded questions about marijuana use and eye health, particularly if they are in a state where medical marijuana is legal.
Though not new, moisture chamber glasses are seeing a resurgence for the treatment of dry eye.
How to manage toric IOL rotation postoperatively and preventative measures to take intraoperatively
Many practitioners are now reaching for Xiidra (lifitegrast, Shire, Lexington, Massachusetts) 5% for dry eye cases, but sometimes a patient may not initially be considered a success. Here’s what leading practitioners are doing to help more patients find respite with Xiidra.
Though FDA approved, the Light Adjustable Lens (LAL, RxSight, Aliso Viejo, California) is not yet currently available in the U.S. Robert Maloney, MD, Los Angeles, John Doane, MD, Leawood, Kansas, David F. Chang, MD, Los Altos, California, and Kevin Waltz, MD, Indianapolis, discussed their experience with the lens in clinical trial, how it works, and for what corrections it has approval.
Two experts share diagnostic pearls to follow and pitfalls to avoid to accurately diagnose this condition.